# The Asahi Intecc PTCA Chronic Total Occlusion Study

Study · id `cardio:ct-nct02379923` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02379923](<https://clinicaltrials.gov/study/NCT02379923>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02379923

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.

## Technical summary

Registry record NCT02379923. Allocation not applicable; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2016-01 (actual). Results posted on 2018-07-18.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 163 participants (enrolled count; ClinicalTrials.gov record NCT02379923, source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT02379923, source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)
- Primary completion: 2016-01 (actual) (ClinicalTrials.gov record NCT02379923, source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)
- Completion: 2016-01 (actual) (ClinicalTrials.gov record NCT02379923, source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)
- Results first posted: 2018-07-18 (ClinicalTrials.gov record NCT02379923, source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02379923, source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02379923-2018-07-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Asahi Intecc PTCA Chronic Total Occlusion Study
- Acronym: CTO-PCI
- Condition: Coronary Artery Disease
- Condition: Coronary Artery Chronic Total Occlusion
- Intervention (Device): Crossing of Coronary Artery CTO
- Lead sponsor: Asahi Intecc USA Inc
- Lead sponsor class: INDUSTRY
- Collaborator: Medpace, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Medpace, Inc. (`cardio:org-medpace-inc`)

## Provenance

Content hash: 67a81a036ed3623b1a84c15ca83ec18a4e7b0b265b3a1e3b23b85f923242da3e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
